Mygene

Page 1

PERSONALIZED GENOMIC ANALYSIS FOR

DISEASE PREDICTION

Introduced by Delancy’s © 2014


02 | Personalized Genomic Analysis for Disease Prediction

WHY DO YOU NEED A

PERSONALIZED GENOMIC ANALYSIS?

You can lead healthier life by adopting an appropriate lifestyle and controlling the diseasecausing environmental factors based on the genetic information related to disease occurrence.


Why do you need a personalized Genomic Analysis | 03

REALIZATION OF ERSONALIZED MEDICINE

HEALTHY LIFE EXTENSION

M CHECK

DISEASE PREVENTION

SYSTEMATIC HEALTHCARE

PARADIGM SHIFT FROM DIAGNOSIS TO PREVENTION It is much better for a disease to be prevented through early prediction (before its onset) than for it to be treated when it has already occurred.

NEW ERA OF PERSONALIZED MEDICINE

An individual’s genetic characteristics must be identified to realize personalized medicine.

HEALTHY LIFE EXTENSION THROUGH HEALTHCARE It is necessary to have personalized healthcare through genome analysis for transition to a healthy life, determining not only how long one can live but also how one can lead a long and healthy life.


04 | Personalized Genomic Analysis for Disease Prediction

WHAT IS

PERSONALIZED GENOMIC ANALYSIS? It is a next-generation personalized healthcare program that predicts the future risk of disease occurrence in a person through genome analysis, and that presents the direction of healthcare management based on the analysis results. It aims to analyze the genes related to the occurrence of a certain disease, such as a chronic disease or cancer, to predict a person’s disease susceptibility or risk.


What is personalized Genomic Analysis | 05

Report example (Report itself approximates 50-100 pages long & comes with a hard copy folder)

HOW CAN I USE IT? CHANGES IN EATING HABITS AND LIFESTYLES In the case of diseases that are greatly influenced by one’s eating habits and lifestyle, such as diabetes or colon cancer, guidelines will be presented to prevent the onset of such diseases, and the patient can consult the doctor(s) in charge.

APPLICATION OF WELLNESS CARE The genome analysis results can be used as basic data for keeping an appropriate diet-exercise-rest-medical diagnosis balance, beyond mere life extension, through prevention, care, and management before disease occurrence.


06 | Personalized Genomic Analysis for Disease Prediction

OUR STRENGTH PERSONALIZED ANALYSIS BY RACE Analysis suitable for each race can be done because we have the required database for such.

MANAGEMENT OF AN AFFILIATED RESEARCH INSTITUTE MEDIZEN HUMANCARE strives to constantly improve the quality of M-CHECK through continuous research at its affiliated research institute.

POSSESSION OF INDEPENDENT ANALYSIS ALGORITHMS MEDIZEN HUMANCARE provides more accurate analysis values through the unique analysis algorithm it developed based on research with genetic statisticians.

PROVISION OF PERSONALIZED HEALTH SOLUTIONS MEDIZEN HUMANCARE provides personalized health solutions in consultation with specialists based on the genome analysis results.

SECURITY OF PERSONAL INFORMATION The sample and genetic information of a customer who has completely consulted about his/her analysis results shall be discarded upon the client’s request, on the same day that the request is made. When a research consent form is accomplished, all samples and personal/genetic information shall automatically be retained and strictly managed through the leak prevention system.


Our strength and what we offer | 07

WHAT WE OFFER Cancer

Cardiovascular diseases

Endocrine diseases

Degenerative diseases

Autoimmune disease

Mental health disorders

Drug reactions

PROCESS OF M-CHECK 1. The testee fills out and signs a test consent form (request form) 2. Saliva samples are collected from the testee and send it to the lab in Seoul, Korea. 3. DNA is extracted from the testee, and the testee’s genomes are analyzed. 4. Analysis results are drawn and delivered to you. (2-3 weeks). 5. The testee consults a specialist about the analysis results if needed.


08 | Personalized Genomic Analysis for Disease Prediction

M-CHECK PACKAGE FEMA LE

A type

B type

Name of Disease (25)

Name of Disease (40)

Lung Cancer Liver Cancer Breast Cancer Thyroid Cancer Cervical Cancer Colorectal Cancer Endometrial Cancer Ovarian Cancer Kidney Cancer Esophageal Cancer Coronary Artery Disease Stroke Cerebral Aneurysm Psoriasis Systemic Lupus Erythematosus Obesity Type 2 Diabetes Osteoporosis Hypertension Alzheimer’s Disease Parkinson’s Disease Osteoarthritis Depression Bi-Polar Disorder Panic Disorder

Lung Cancer Liver Cancer Breast Cancer Thyroid Cancer Cervical Cancer Colorectal Cancer Stomach Cancer Diffuse-Type Gastric Cancer Pancreatic Cancer Bladder Cancer Endometrial Cancer Acute Myeloid Leukemia Gallbladder Cancer Ovarian Cancer Kidney Cancer Esophageal Cancer Non-Hodgkin’s Lymphoma Coronary Artery Disease Myocardial Infarction Atrial Fibrillation Stroke Cerebral Aneurysm Psoriasis Systemic Lupus Erythematosus Chronic Hepatitis C Knee Osteoarthritis Rheumatoid Arthritis Rheumatic Heart Disease Glaucoma Obesity Type 1 Diabetes Type 2 Diabetes Osteoporosis Hypertension Alzheimer’s Disease Parkinson’s Disease Osteoarthritis Depression Bi-Polar Disorder Panic Disorder


What we offer and process of M-check | 09

MA LE

A type

B type

Name of Disease (25)

Name of Disease (40)

Lung Cancer Liver Cancer Stomach Cancer Colorectal Cancer Thyroid Cancer Prostate Cancer Diffuse-Type Gastric Cancer Pancreatic Cancer Esophageal Cancer Kidney Cancer Coronary Artery Disease Stroke Cerebral Aneurysm Gout Chronic Hepatitis C Knee Osteoarthritis Obesity Type 2 Diabetes Hypertension Alzheimer’s Disease Parkinson’s Disease Osteoarthritis Depression Bi-Polar Disorder Schizophrenia

Lung Cancer Liver Cancer Stomach Cancer Colorectal Cancer Thyroid Cancer Prostate Cancer Diffuse-Type Gastric Cancer Pancreatic Cancer Bladder Cancer Esophageal Cancer Kidney Cancer Acute Myeloid Leukemia Gallbladder Cancer Non-Hodgkin’s Lymphoma Coronary Artery Disease Myocardial Infarction Atrial Fibrillation Stroke Cerebral Aneurysm Asthma Gout Systemic Lupus Erythematosus Ulcerative Colitis Chronic Hepatitis C Knee Osteoarthritis Rheumatoid Arthritis Rheumatic Heart Disease Glaucoma Age-related Macular Degeneration Obesity Type 1 Diabetes Type 2 Diabetes Hypertension Alzheimer’s Disease Parkinson’s Disease Osteoarthritis Depression Bi-Polar Disorder Schizophrenia Panic Disorder


10 | Personalized Genomic Analysis for Disease Prediction

WHO ARE WE? MEDIZEN HUMANCARE is a trustworthy company leading the field of disease prediction, with unusual-disease-related gene contents and long-accumulated knowledge and skills related to result interpretation through disease genome research by race. It is also a professional research institute that devotes itself to identifying disease-related gene contents and new-drug candidate genes, and to developing new disease prevention methods with the most advanced genome research techniques and analysis devices. MEDIZEN HUMANCARE aims to establish a complete disease prediction system suitable for many different races through continuous genome analysis and research and the discovery of disease-related genes at its affiliated research institute, which acquired the certification of Korea Industrial Technology Association (KOITA). The research team is composed of researchers specializing in medical science, genetics, molecular biology, biochemistry, statistics, bioinformatics, and clinical pathology.


Who are we | 11

Delancy’s Pte Ltd is Medizen Humancare’s strategic South Asian arm based in Singpaore. We aim to offer direct access to world class biotechnology in preventative and age-defying services in Seoul, Korea.


Introduced by Delancy’s © 2014

Level 25 One Raffles Quay North Tower, Singapore 048583 M: +65 8223 9030 T : +65 6622 5856 E: lauren.kim@delancysgroup.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.